Editas Medicine (EDIT) Releases Earnings Results, Misses Expectations By $-0.48 EPS

Editas Medicine (EDIT) reported quarterly earnings results on Monday, May-16-2016. The company reported $-0.80 earnings per share for the quarter, missing the analyst consensus estimate by $-0.48. Analysts had a consensus of $-0.32. The company posted revenue of $.80 million in the period, compared to analysts expectations of $1.08 million.

Many Wall Street Analysts have commented on Editas Medicine. Editas Medicine was Initiated by JMP Securities to “Mkt Outperform” on Feb 29, 2016. Editas Medicine was Initiated by JP Morgan to “Neutral” on Feb 29, 2016. Morgan Stanley Initiated Editas Medicine on Feb 29, 2016 to “Equal-Weight”, Price Target of the shares are set at $28.

Editas Medicine

Leave a Reply

Editas Medicine - Is it time to Sell?

Top Brokerage Firms are advising their investors on Editas Medicine. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.